EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid™ Cleanser. The product is being introduced at the American Society of Cataract and Refractive Surgery (booth number 583) being held in Boston, MA, April 25-29, 2014. Already cleared by the FDA through its 510(k) process, NovaBay’s Advanced i-Lid Cleanser can help patients with irritation of their eyelids by cleaning their lids and lashes and removing debris and microorganisms that often lead to vision problems.
Help employers find you! Check out all the jobs and post your resume.
